SARIN RAVI YANG 4
4 · Oncology Institute, Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
SARIN RAVI YANG
Director
Transactions
- Award
Common stock
2022-03-21+15,994→ 15,994 total - Award
Common stock
2022-03-21+7,197→ 23,191 total
Holdings
- 4,109,771(indirect: By LLC)
Common stock
Footnotes (2)
- [F1]Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date.
- [F2]Reflects securities owned by OncologyCare Partners, LLC. OncologyCare Holdings, LLC is the manager of OncologyCare Partners, LLC, and, Ravi Sarin formerly served as the managing member of OncologyCare Holdings, LLC and continues to have the ability to influence the vote and disposition of the shares in certain circumstances, and thus may be deemed to indirectly beneficially own the shares, which Mr. Ravi disclaims except to the extent of his pecuniary interest therein.